Related by context. Frequent words. (Click for all words.) 70 oncolytic virus therapies 69 recombinant vaccines 65 GRNVAC1 65 nasal powder 65 based pretargeting methods 64 MediVas 64 Initiates Phase II 63 Nasdaq CRXL 63 bio therapeutics 62 optical biosensors 62 aesthetic medicine BioLook 62 Emergent marketed 62 staphylococcal vaccines 62 Completes Patient Enrollment 62 Litx 62 BiTE R 61 Affymetrix GeneChip ® 61 therapeutic monoclonal antibodies 61 VaxInnate 61 NASDAQ CRXL 61 PER.C6 ® 61 Crucell NV NYSE Euronext 61 MassARRAY R 61 immunotherapeutics 61 commercializes therapeutic proteins 61 Lipid Polymer Micelle LPM 61 Nuclear Pharm Assist 61 Taiho Pharmaceutical 61 low toxicity bioscience 61 vivo electroporation 61 hepatitis C lupus 61 Vaccinex 61 PER.C6 61 Factor VIIa 61 XOMA proprietary 61 markets therapeutic ultrasonic 61 SonoPrep 61 GVAX cancer 60 Receptos 60 ViaCyte 60 CPL Biologicals 60 silver dihydrogen citrate 60 Advancing Wellness 60 Inovio Pharmaceuticals 60 polyclonal antibody 60 AutovaxID 60 Bayhill Therapeutics 60 Ibis T# 60 treat male hypogonadism 60 Halozyme Therapeutics 60 Xcellerex 60 gets USFDA nod 60 XOMA discovers develops 60 KaloBios 60 GTC Biotherapeutics develops 60 Biolex Therapeutics 60 unique PER.C6 ® 60 Shigamabs R 60 topically delivered 60 Wound Dressing 60 Scancell 60 developing Zerenex TM 60 proprietary adenovector technology 60 proprietary Mimetic Ligand 60 commercial bioproduction 60 Presents Positive 60 Xyntha 60 topical anti infective 60 Inc. Nasdaq NEXM 60 Nautilus Biotech 60 Elusys 60 particle VLP 60 MVA BN R 59 Receives Orphan Drug Designation 59 Agios Pharmaceuticals 59 Panzem 59 leading lipid nanoparticle 59 non personalized allogeneic 59 novel anti infective 59 Althea Technologies 59 using BioSante patented 59 LGLS 59 Regado Biosciences 59 Tesetaxel 59 Inc. Nasdaq INFI 59 commercializing therapeutic 59 Takara Bio 59 Baxa customer 59 Cerus Corporation 59 DermaVir Patch 59 Pazopanib 59 Chemokine Therapeutics 59 Inc Therapeutic Competitors 59 liposomal formulation 59 HIV protease inhibitor Lexiva 59 Biomagnetics Diagnostics Corporation 59 XYNTHA 59 Exploit collaboration 59 novel antibody therapeutics 59 MultiCell Technologies 59 Time PCR